Price and availability of chronic medicines | WHO & HAI
“There is strong scientific evidence that cost-effective medications can contribute to substantial individual and public health benefits […] The time has now come for WHO once again to take the lead in introducing a global effort wherein all partners are engaged in a concerted effort to make good quality medicines for chronic, or noncommunicable, diseases affordable and available to the poor and needy suffering from these diseases — an initiative that will help to lift the poor out of the devastating spiral of poverty and chronic disease.”
“Price, Availability, and Affordability: An International Comparison of Chronic Disease Medicines” is a background report prepared for the WHO Planning Meeting on the Global Initiative of Chronic Diseases held in Cairo, Egypt in December 2005. The publication was developed through a collaboration between the WHO Regional Office for the Eastern Mediterranean and Health Action International (HAI), with financial assistance of the European Community.
Medicines included in the analysis include the following conditions: asthma, diabetes, hypertension, epilepsy, and psychiatric disorders.
The report includes sections on:
- Methodology – WHO/HAI Medicine Price survey
- Secondary analysis methods
- Results – asthma, diabetes, hypertension, epilepsy, psychiatric disorders
- Price components
- Policy options